2m 2m 2m 2m 2m 2m 2m
Invivyd (IVVD)
NASDAQ
$1.09-$0.05 (-4.04%)
Price as of Jun 03, 2026 7:48 PM EDT- $335.9MMarket Cap
- 17.98%1-Year Change
- BiotechnologyIndustry
Invivyd (IVVD)
$1.09-$0.05 (-4.04%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 53.4M +110.47% | 25.4M N/A | N/A N/A | 0 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 53.4M +110.47% | 25.4M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 66.9M +5.59% | 63.4M +29.03% | 49.1M +4.42% | 47.0M +28.83% | |
Research and Development Expense | -38.3M -72.09% | -137.3M -13.49% | -158.7M -11.47% | -179.2M -2.01% | |
Depreciation and Amortization Expense | 755,000 -48.50% | 1.5M +205.42% | 480,000 +1,070.73% | 41,000 +4,000.00% | |
Total Operating Expenses | 109.0M -46.12% | 202.3M -4.93% | 212.8M -14.22% | 248.0M +9.31% | |
Operating Profit | -55.6M -68.59% | -176.9M -16.87% | -212.8M -14.22% | -248.0M +9.31% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 3.1M -55.82% | 7.0M -50.75% | 14.1M +110.23% | 6.7M +5,589.83% | |
Income before Taxes | -55.6M -68.59% | -176.9M -16.87% | -212.8M -14.22% | -248.0M +9.31% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -52.5M -69.11% | -169.9M -14.46% | -198.6M -17.68% | -241.3M +6.41% | |
Net Income from Continuing Operations Applicable to Common | -52.5M -69.11% | -169.9M -14.46% | -198.6M -17.68% | -241.3M +6.41% | |
Basic EPS and Net Income | -0.30 -79.02% | -1.43 -20.99% | -1.81 -18.83% | -2.23 -58.08% | |
Diluted EPS and Net Income | -0.30 -79.02% | -1.43 -20.99% | -1.81 -18.83% | -2.23 -58.08% | |
Basic Weighted Average Shares | 172.2M +45.26% | 118.6M +8.24% | 109.5M +1.16% | 108.3M +154.02% | |
Diluted Weighted Average Shares | 172.2M +45.26% | 118.6M +8.24% | 109.5M +1.16% | 108.3M +154.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 226.7M +226.88% | 69.3M -65.44% | 200.6M +117.91% | 92.1M -83.02% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 226.7M +226.88% | 69.3M -65.44% | 200.6M +117.91% | 92.1M -83.02% | |
Total Current Assets | 247.5M +145.79% | 100.7M -55.23% | 224.9M -40.34% | 376.9M -38.88% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.4M -9.48% | 1.5M -20.46% | 1.9M -16.91% | 2.3M +2,649.40% | |
Total Long-Term Assets | 110,000 +223.53% | 34,000 -80.57% | 175,000 -8.38% | 191,000 -94.21% | |
Total Assets | 276.9M +113.78% | 129.5M -43.49% | 229.2M -40.19% | 383.2M -38.21% | |
Income Taxes Payable | 19.1M -62.04% | 50.2M +22.85% | 40.9M +86.48% | 21.9M -61.07% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 34.2M -44.88% | 62.0M +23.23% | 50.3M +100.91% | 25.0M -59.67% | |
Total Long-Term Debt | 1.0B 0.00% | 1.0B 0.00% | 1.0B 0.00% | 1.0B N/A | |
Total Long-Term Liabilities | 1.2M N/A | 0 -100.00% | 700,000 N/A | 0 -100.00% | |
Total Liabilities | 35.3M -42.97% | 62.0M +19.85% | 51.7M +90.14% | 27.2M -56.18% | |
Retained Earnings | -954.5M +5.82% | -902.0M +23.21% | -732.1M +37.24% | -533.4M +82.61% | |
Total Stockholders Equity | 241.5M +257.63% | 67.5M -61.94% | 177.5M -50.15% | 356.0M -36.21% | |
Total Shares Outstanding | 282.0M +135.31% | 119.8M +8.78% | 110.2M +1.02% | 109.0M -1.57% | |
Cash Flow | |||||
Cash from Operating Activities | -58.1M -65.90% | -170.5M -1.54% | -173.2M -21.28% | -220.0M +19.08% | |
Capital Expenditures | 155,000 +10.71% | 140,000 -77.24% | 615,000 -63.93% | 1.7M +1,929.76% | |
Cash from Investing Activities | -155,000 +10.71% | -140,000 -100.05% | 280.7M +221.68% | -230.7M +354.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 215.6M +448.24% | 39.3M +3,663.73% | 1.0M +106.52% | 506,000 -99.92% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -103.99% -85.08% | -696.80% N/A | N/A N/A | N/A N/A | |
Return on Assets | -25.83% -72.74% | -94.75% +46.03% | -64.88% +34.86% | -48.11% N/A | |
Return on Equity | -33.96% -75.51% | -138.71% +86.25% | -74.48% +41.04% | -52.81% N/A | |
Revenue Growth | 110.47% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 7.24 +345.90% | 1.62 -63.67% | 4.47 -70.30% | 15.06 N/A | |
Cash Ratio | 6.64 +492.98% | 1.12 -71.95% | 3.99 +8.46% | 3.68 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow